SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Author(s) -
Alexandra C. Walls,
Kaitlin R. Sprouse,
John E. Bowen,
Anshu Joshi,
Nicholas Franko,
Mary Jane Navarro,
Cameron Stewart,
Elisabetta Cameroni,
Matthew McCallum,
Erin Goecker,
Emily Degli-Angeli,
Jenni Logue,
Alexander L. Greninger,
Davide Corti,
Helen Y. Chu,
David Veesler
Publication year - 2022
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2022.01.011
Subject(s) - neutralizing antibody , biology , immunology , antibody , neutralization , virology , immunity , antibody response , covid-19 , pandemic , vaccination , anthrax vaccines , antibody dependent enhancement , immune system , virus , immunization , medicine , disease , infectious disease (medical specialty) , viral replication , dna vaccination
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom